PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19882073-3	2009	SCH 530348, a potent thrombin receptor antagonist (TRA) selective for PAR-1, has been evaluated in preclinical studies, demonstrating complete and sustained inhibition of thrombin/TRAP-induced platelet aggregation without a concomitant increase in the risk of bleeding.	vorapaxar	0-10	T cell receptor alpha locus	Homo sapiens	51-54	
18574020-12	2008	A new oral antiplatelet thrombin-receptor antagonist, TRA-SCH 530348, is in early clinical trials.	vorapaxar	58-68	T cell receptor alpha locus	Homo sapiens	54-57